PrEP coverage is marked by significant disparities across race/ethnicity. What’s happening in RI to combat this?
Did you know that we can’t compare the MIC for one drug to another?
Did you know that the sequence of how antibiotics are administered can have a dramatic affect on outcomes in patients with bloodstream infections?
Lots of antibodies to create confusion: heterophile, IgM-VCA, IgG-VCA, IgG-EBNA, IgG-EA. Do you know their significance?
Did you know that we should repeat titers at 6 and 12 months after treating a patient for syphilis?
What’s the difference between PrEP and PEP? How effective are they? Who’s eligible?
Febrile infants have higher rates of invasive bacterial infections. Do you know what work-up is recommended?
Recognizing monkeypox can be tricky–better add it to your differential.
For HIV-uninfected patients, pre-exposure prophylaxis (PrEP) using antiretroviral medications is an evidence-based way to prevent new infections among those at high risk for HIV. Typical use is once daily every day, but what about on-demand use?
Let’s review some updates on forum topics from the past year: lung cancer screening, gonorrhea testing and management, and primary aldosteronism.